Chemoinformaics analysis of imbricatolic-acid
| Molecular Weight | 124.183 | nRot | 3 |
| Heavy Atom Molecular Weight | 112.087 | nRig | 2 |
| Exact Molecular Weight | 124.089 | nRing | 0 |
| Solubility: LogS | -6.244 | nHRing | 0 |
| Solubility: LogP | 7.12 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 22.1635 |
| nHD | 0 | BPOL | 12.9065 |
| QED | 0.195 |
| Synth | 2.26 |
| Natural Product Likeliness | 1.127 |
| NR-PPAR-gamma | 0.68 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.002 |
| HIA | 0.005 |
| CACO-2 | -4.753 |
| MDCK | 0.0000116 |
| BBB | 0.798 |
| PPB | 0.960738 |
| VDSS | 3.799 |
| FU | 0.0171372 |
| CYP1A2-inh | 0.373 |
| CYP1A2-sub | 0.187 |
| CYP2c19-inh | 0.4 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.216 |
| CYP2c9-sub | 0.946 |
| CYP2d6-inh | 0.393 |
| CYP2d6-sub | 0.185 |
| CYP3a4-inh | 0.354 |
| CYP3a4-sub | 0.041 |
| CL | 4.043 |
| T12 | 0.14 |
| hERG | 0.267 |
| Ames | 0.018 |
| ROA | 0.009 |
| SkinSen | 0.983 |
| Carcinogencity | 0.179 |
| EI | 0.948 |
| Respiratory | 0.932 |
| NR-Aromatase | 0.323 |
| Antiviral | No |
| Prediction | 0.956486 |